Decreased vasomotor effect of endothelin on the coronary arteries during angioplasty in hypertensive patients

Int J Cardiol. 1996 Jul 5;55(1):41-8. doi: 10.1016/0167-5273(96)02653-8.

Abstract

To investigate if the response of the contralateral artery during coronary angioplasty (PTCA) is different in hypertensive than in normotensive patients and whether this response is related to plasma levels of endothelin-1 (ET-1). We examined the change in ET-1 plasma levels and the reactivity of the left circumflex artery (LCx) during PTCA of the left anterior descending branch in 10 hypertensive and 23 normotensive patients. Peripheral vein blood samples were drawn for ET-1 estimation at baseline, after the end of the first balloon inflation, at the end of PTCA, and 4 h later. Angiograms of the LCx were obtained at baseline and during the 1st balloon inflation. The ET-1 level in hypertensives increased from 6.81 +/- 3.76 at baseline to 7.54 +/- 4.76 pmol/l (P = n.s.) at the end of PTCA, while in normotensives it increased from 8.21 +/- 3.73 to 11.56 +/- 5.04 pmol/l (F = 7.48, P = 0.0002) respectively. The LCx distal segment diameter increased from 1.29 to 1.50 mm during balloon inflation in hypertensive, and from 1.44 to 1.53 mm (F = 5.03, P = 0.03) in normotensives. The diameter increase was related to the baseline ET-1 level (r = -0.67, P = 0.005) in the normotensives, but not in the hypertensives. Thus ET-1 has a weaker vasomotion effect on the coronary vasculature in hypertensives than in normotensives during PTCA.

MeSH terms

  • Adult
  • Aged
  • Angioplasty, Balloon, Coronary*
  • Blood Pressure
  • Coronary Vessels / physiopathology*
  • Endothelin-1 / blood*
  • Female
  • Humans
  • Hypertension / blood
  • Hypertension / complications
  • Hypertension / physiopathology*
  • Male
  • Middle Aged
  • Muscle, Smooth, Vascular / physiopathology*
  • Myocardial Ischemia / blood
  • Myocardial Ischemia / complications
  • Myocardial Ischemia / therapy*
  • Radioimmunoassay
  • Vasoconstriction

Substances

  • Endothelin-1